Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OVOS1P, or ovostatin 1 pseudogene, is a **pseudogene** related to the ovostatin family of protease inhibitors[4][6][7]. The functional ovostatin (not the pseudogene) is a large, tetrameric protein originally isolated from chicken egg white, known for its ability to inhibit metalloproteases and acid proteases through a unique trapping mechanism[1][5]. However, OVOS1P and related pseudogenes do not encode functional proteins and are not considered enzymes, receptors, or drug targets. The "pseudogene" status means it is a non-functional, non-coding remnant of a gene and lacks biological or therapeutic activity[7][6]. Therefore, "ovostatin 1, pseudogene" should not be considered a therapeutic target. Note: There may be confusion due to the overlap with functional ovostatin proteins (e.g., OVM, ovomacroglobulin), which are legitimate protease inhibitors with structural and functional similarity to alpha-2-macroglobulin[1][5]. However, the "pseudogene" form is non-functional and is not a valid target for drug discovery or therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ovostatin 1 pseudogene (OVOS1P).